Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of a Meropenem Dosage Strategy Based on a Population Pharmacokinetic-pharmacodynamic Model in Lower Respiratory Tract Infection Patients

NCT01944319 is registered in ClinicalTrials.gov with Qingtao Zhou as lead sponsor.

NCT NCT01944319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01944319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of a Meropenem Dosage Strategy Based on a Population Pharmacokinetic-pharmacodynamic Model in Lower Respiratory Tract Infection Patients
Lead sponsor
Qingtao Zhou
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2013
Completion date
October 31, 2015
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lower respiratory tract infection